Teladoc Health, Inc.
TDOC Healthcare Health Information Services
Teladoc Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, down 1.54% from fiscal 2024. In the quarter to June 2026, revenue fell 3.95%, EPS fell 10.5%, free cash flow fell 27.1% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow TDOC
Teladoc Health, Inc. (TDOC) EV/Sales
As of 16 October 2026, Teladoc Health, Inc. (TDOC) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from 0.6× (April 2025) to 26.1× (August 2020); the current reading is higher than 17% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.8× | 13.10% |
| FY2024 | 0.7× | (54.97%) |
| FY2023 | 1.6× | (12.74%) |
| FY2022 | 1.8× | (75.52%) |
| FY2021 | 7.3× | (57.62%) |
| FY2020 | 17.1× | 59.43% |
| FY2019 | 10.7× | 40.19% |
| FY2018 | 7.7× | (14.62%) |
| FY2017 | 9.0× | 63.24% |
| FY2016 | 5.5× | 72.35% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.1× | 56.95% |
| Mar 2026 | 0.7× | (10.77%) |
| Dec 2025 | 0.8× | (8.66%) |
| Sep 2025 | 0.9× | (8.27%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDRX Veradigm Inc. compare | 0.6× |
| TDOC Teladoc Health, Inc. | 0.9× |
| OMCL Omnicell, Inc. compare | 1.3× |
| PHR Phreesia, Inc. compare | 1.5× |
| GDRX GoodRx Holdings, Inc. compare | 1.7× |
| OMDA Omada Health, Inc. compare | 2.8× |
| HSTM HealthStream, Inc. compare | 2.9× |
| CERT Certara, Inc. compare | 3.7× |
| SOPH SOPHiA GENETICS SA compare | 5.1× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)